RPA Women and Babies – Changes in Combined First Trimester aneuploidy and pre-eclampsia screening and provision of non-invasive prenatal testing (NIPT)

RPA will be introducing some changes in their aneuploidy/pre-eclampsia screening including:

  • addition of a third biochemical marker for combined first trimester screening
  • timing and process for blood collection for first trimester serology
  • delivery of first trimester screening results
  • “contingent” model for Non-Invasive Prenatal Testing (NIPT) and service provision
  • pre-eclampsia risk assessment

Information pertaining to these changes is outlined in the pdf memo (663 KB) from Dr Ritu Mogra and Clinical Professor Jon Hyett.

As outlined in the memo, there are a number of new and updated resources relating to RPA prenatal screening service. These are listed below: